Celanese Corp CE
We take great care to ensure that the data presented and summarized in this overview for Celanese Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CE
View all-
Dodge & Cox San Francisco, CA13.6MShares$740 Million0.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$717 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA7.37MShares$400 Million0.1% of portfolio
-
Black Rock Inc. New York, NY7.15MShares$388 Million0.02% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.55MShares$247 Million0.07% of portfolio
-
State Street Corp Boston, MA4.48MShares$244 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.97MShares$216 Million0.05% of portfolio
-
Turtle Creek Asset Management Inc. Toronto, A63.51MShares$191 Million6.77% of portfolio
-
Norges Bank Oslo, Q83.22MShares$175 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA2.68MShares$146 Million0.01% of portfolio
Latest Institutional Activity in CE
Top Purchases
Top Sells
About CE
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.
Insider Transactions at CE
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 12
2025
|
Ganesh Moorthy Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+25.0%
|
$53,000
$53.29 P/Share
|
Mar 07
2025
|
Mark Christopher Murray SVP - Acetyls |
BUY
Open market or private purchase
|
Direct |
2,353
+14.4%
|
$127,062
$54.45 P/Share
|
Mar 07
2025
|
Scott Mc Dougald Sutton Director |
BUY
Open market or private purchase
|
Direct |
7,450
+33.18%
|
$402,300
$54.65 P/Share
|
Mar 07
2025
|
Deborah J. Kissire Director |
BUY
Open market or private purchase
|
Direct |
1,000
+31.11%
|
$54,000
$54.28 P/Share
|
Mar 07
2025
|
Ganesh Moorthy Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+33.33%
|
$54,000
$54.67 P/Share
|
Feb 15
2025
|
Ashley B Duffie SVP & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-1.24%
|
$12,006
$69.13 P/Share
|
Feb 15
2025
|
Ashley B Duffie SVP & GC |
BUY
Grant, award, or other acquisition
|
Direct |
412
+2.86%
|
-
|
Feb 15
2025
|
Chuck Kyrish SVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-4.32%
|
$18,423
$69.13 P/Share
|
Feb 15
2025
|
Chuck Kyrish SVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
412
+6.25%
|
-
|
Feb 15
2025
|
Aaron M Mc Gilvray Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-1.2%
|
$4,968
$69.13 P/Share
|
Feb 15
2025
|
Aaron M Mc Gilvray Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158
+2.56%
|
-
|
Feb 15
2025
|
Mark Christopher Murray SVP - Acetyls |
SELL
Payment of exercise price or tax liability
|
Direct |
364
-3.03%
|
$25,116
$69.13 P/Share
|
Feb 15
2025
|
Mark Christopher Murray SVP - Acetyls |
BUY
Grant, award, or other acquisition
|
Direct |
871
+6.77%
|
-
|
Feb 15
2025
|
Scott A Richardson CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
964
-1.43%
|
$66,516
$69.13 P/Share
|
Feb 15
2025
|
Scott A Richardson CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
2,534
+3.61%
|
-
|
Sep 15
2024
|
Bruce E. Chinn Director |
BUY
Grant, award, or other acquisition
|
Direct |
910
+50.0%
|
-
|
Aug 20
2024
|
Scott A Richardson CEO & President |
SELL
Open market or private sale
|
Direct |
4,675
-6.7%
|
$603,075
$129.41 P/Share
|
Aug 19
2024
|
Scott A Richardson CEO & President |
SELL
Open market or private sale
|
Direct |
4,675
-6.28%
|
$603,075
$129.51 P/Share
|
Jul 13
2024
|
Mark Christopher Murray SVP - Acetyls |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-4.06%
|
$65,940
$140.58 P/Share
|
May 15
2024
|
Kim K.W. Rucker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+48.77%
|
$173,784
$156.96 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 15.3K shares |
---|---|
Open market or private purchase | 12.8K shares |
Sale (or disposition) back to the issuer | 7.11K shares |
---|---|
Payment of exercise price or tax liability | 2.85K shares |
Open market or private sale | 11.4K shares |